Ffrdc space management task order (leases)

Ended Awarded Last action

Contract number
75N91019F00133
Awardee
Awarding agency
Obligated
$126,402,596

Award facts

Opportunity
  • N02CO7240681 Solicitation number
Contract value 97% obligated
  • $127,122,171.00 Current, with exercised options
  • $130,363,640.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00025 · FY26 UDO initiative - ffrdc task order - leases -$2,195
Supplemental Agreement for work within scope P00024 $160,025
Supplemental Agreement for work within scope P00023 $3,835,745
Other Administrative Action P00022 $0
Exercise an Option P00021 $21,906,480
Supplemental Agreement for work within scope P00020 $591,107
Supplemental Agreement for work within scope P00019 $2,021,088
Exercise an Option P00018 $22,412,787
Change Order P00017 $636,010
Supplemental Agreement for work within scope P00016 $1,000,000
Supplemental Agreement for work within scope P00015 $788,300
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Funding Only Action P00012 $14,000,000
Exercise an Option P00011 $8,771,030
Funding Only Action P00010 $626,739
Other Administrative Action P00009 $1,000,000
Other Administrative Action P00008 $500,000
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $14,000,000
Other Administrative Action P00004 $8,562,829
Other Administrative Action P00003 $909,297
Other Administrative Action P00002 $0
Additional Work (new agreement, FAR part 6 applies) P00001 · Ffrdc task order - leases $2,483,600
Original award $22,199,754
Show all 26

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 30, 2019, with a ceiling value of $130.4 million for FFRDC space management and lease services.

Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute and National Institutes of Health, providing biomedical research and facilities support. Place of performance is Frederick, MD 21702. The order carries an ultimate completion date of August 30, 2024, and is priced on a cost-plus-fixed-fee basis.

Service Contract Inventory reporting shows government-invoiced labor across five fiscal years. FY2024 recorded $24.3 million invoiced against 0.3 FTEs and 575 contractor hours, with a derived government-paid rate of $42,359.64 per hour. FY2023 invoiced $24.8 million across 0.2 FTEs and 463 hours at $53,537.07 per hour. FY2022 invoiced $23.7 million across 0.2 FTEs and 337 hours at $70,123.11 per hour. FY2021 invoiced $22.9 million across 0.3 FTEs and 681 hours at $33,637.94 per hour. FY2020 invoiced $25.8 million. The prime self-performed all reported hours with no subcontractors.

Quick answers

Who was awarded contract 75N91019F00133?

75N91019F00133 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 30, 2019.

How much is contract 75N91019F00133 worth?

The government has obligated $126,402,596 on 75N91019F00133. Its current value, with exercised options, is $127,122,171. Its potential value, with all options, is $130,363,640.

Is contract 75N91019F00133 an order under another contract?

Yes. 75N91019F00133 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91019F00133 competed?

The extent of competition for 75N91019F00133 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login